Ensuring access to injectable generic drugs - The case of intravesical BCG for bladder cancer

New England Journal of Medicine

Volumn 376, Issue 15, 2017, Pages 1401-1403

  Davies, Benjamin J ^a   Hwang, Thomas J ^b   Kesselheim, Aaron S ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GENERIC DRUG; GLYCOPYRRONIUM; MITOMYCIN; THIOTEPA; VALRUBICIN; ANTINEOPLASTIC AGENT;

BLADDER CANCER; CANCER IMMUNOTHERAPY; DRUG COST; DRUG INDUSTRY; DRUG MANUFACTURE; FOOD AND DRUG ADMINISTRATION; GOVERNMENT REGULATION; HEALTH CARE ACCESS; HUMAN; LICENSING; MEDICARE; NON MUSCLE INVASIVE BLADDER CANCER; PHARMACY; REIMBURSEMENT; REVIEW; DRUG APPROVAL; ECONOMICS; HEALTH CARE COST; HEALTH CARE DELIVERY; INTRAVESICAL DRUG ADMINISTRATION; SUPPLY AND DISTRIBUTION; TRENDS; UNITED STATES; URINARY BLADDER NEOPLASMS;

ADMINISTRATION, INTRAVESICAL; ANTINEOPLASTIC AGENTS; BCG VACCINE; DRUG APPROVAL; DRUG COSTS; DRUGS, GENERIC; HEALTH CARE COSTS; HEALTH SERVICES ACCESSIBILITY; HUMANS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; URINARY BLADDER NEOPLASMS;

EID: 85018460674     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1615697     Document Type: Review

References (5)

1. Davies B. Sanofi shuts down bladder cancer drug production: inevitable drug shortage to harm patients. Forbes. November 17, 2016 (http://www.forbes.com/sites/benjamindavies/2016/11/17/sanofi-shuts-down-bladder-cancer-drug-production-inevitable-drug-shortage-to-harm-patients).
2. Metzger ML, Billett A, Link MP. The impact of drug shortages on children with cancer - the example of mechlorethamine. N Engl J Med 2012; 367: 2461-3.
3. Centers for Medicare and Medicaid Services. CMS drug spending: Medicare drug spending dashboard. 2015 (https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Information-on-Prescription-Drugs/).
4. Government Accountability Office. Drug shortages: certain factors are strongly associated with this persistent public health challenge. July 7, 2016 (http://www.gao.gov/products/GAO-16-595).
5. Chen SI, Fox ER, Hall MK, et al. Despite federal legislation, shortages of drugs used in acute care settings remain persistent and prolonged. Health Aff (Millwood) 2016; 35: 798-804.